Raija Silvennoinen

7PUBLICATIONS
30CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)MortalityMedical genetics (excl. cancer genetics)Immunogenetics (incl. genetic immunology)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 13, 2024
Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group.

Anu Partanen, Anders Waage, Valdas Peceliunas

|Mar 12, 2024
Large differencies in age-specific survival in multiple myeloma in the nordic countries.

Kari Hemminki, Frantisek Zitricky, Asta Försti

|Oct 13, 2023
Real-world evidence of multiple myeloma treated from 2013 to 2019 in the Hospital District of Helsinki and Uusimaa, Finland.

Johanna Vikkula, Kristiina Uusi-Rauva, Tuuli Ranki

|May 13, 2023
Deep Immune Profiling of Multiple Myeloma at Diagnosis and under Lenalidomide Maintenance Therapy.

Sini Luoma, Philipp Sergeev, Komal Kumar Javarappa

|Dec 05, 2022
A germline exome analysis reveals harmful POT1 variants in multiple myeloma patients and families.

Marja Hakkarainen, Jessica R Koski, Caroline A Heckman

|May 31, 2022
Efficacy of conventional-dose cytarabine, idarubicin and thioguanine versus intermediate-dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long-term results of the prospective randomized nationwide AML-2003 study by the Finnish Leukemia Group.

Aarne Kolonen, Marjatta Sinisalo, Heini Huhtala

Pageof 2

Frequent Collaborators

3 joint publications

Caroline A Heckman

2 joint publications

Pekka Anttila

1 joint publications

Juho J Miettinen

1 joint publications

Romika Kumari